Go Pro

Harry Gillis Analyst Performance

Analyst at Berenberg Bank

Harry Gillis is a stock analyst at Berenberg Bank in the healthcare sector, covering 2 publicly traded companies. Over the past year, Harry Gillis has issued 3 stock ratings, including buy and hold recommendations. While full access to Harry Gillis' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Harry Gillis' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
3 Last 0 Years
Buy Recommendations
66.67% 2 Buy Ratings
Companies Covered
2 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy66.7%2 ratings
Hold33.3%1 ratings
Sell0.0%0 ratings

Out of 3 total stock ratings issued by Harry Gillis at Berenberg Bank, the majority (66.7%) have been Buy recommendations, followed by 33.3% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
50.0% of companies on NYSE
1 company
NASDAQ
50.0% of companies on NASDAQ
1 company

Harry Gillis, an analyst at Berenberg Bank, currently covers 2 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Healthcare
2 companies
100.0%

Harry Gillis of Berenberg Bank specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
LIFE SCIENCES TOOLS & SERVICES
1 company
50.0%
BIOTECHNOLOGY
1 company
50.0%

Harry Gillis' Ratings History at Berenberg Bank

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Qiagen N.V. stock logo
QGEN
Qiagen
7/14/2026Set Price Target$41.44$45.50Hold
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
1/23/2026Reiterated Rating$118.47Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
12/11/2025Boost Price Target$95.74$155.00Buy